Skip to menu Skip to content Skip to footer

A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa (Initiation trial for 1 year) (2013-2014)

Experts

Professor Peter Soyer

Interim Director, Frazer Institute
Faculty of Medicine
Peter Soyer
Peter Soyer

Associate Professor Erin McMeniman

Principal Research Fellow
Frazer Institute
Faculty of Medicine
ATH - Associate Professor
PA Southside Clinical Unit
Faculty of Medicine
Erin McMeniman